Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 16 of 16 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company BioRxn LLC | Activity: Research and Development | Company Description BioRxn develops NMR-based metabolomic technology, including bioreactor and artificial liver systems, for non-invasive monitoring of metabolic biomarkers. BioRxn also provides conventional metabolomic services. | Location Chapel Hill |
| |
Company Codetta Bio Inc. | Activity: Research and Development | Company Description Codetta Biosciences is developing a unique digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsiPCR) platform for multi-omic analysis from a single specimen. | Location Durham |
| |
Company Cognosci Inc. | Activity: Research and Development | Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. | Location Durham |
| |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park |
| |
Company Glycan Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Glycan Therapeutics offers solutions for design, synthesis, analysis, and validation of glycosaminoglycans (GAGs), specifically heparan sulfate and chondroitin sulfate. Glycan Therapeutics offers research reagents, analytical and microarray services, and a drug development program. | Location Raleigh |
| |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park |
| |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill |
| |
Company Integrated Precision Metabolomics | Activity: Research and Development | Company Description Integrated Precision Metabolomics is developing a new type of mass spectrometer instrumentation and related software that will enable easier metabolomics analysis by end users. | Location Chapel Hill |
| |
Company Juno Metabolomics LLC | Activity: Production and Manufacturing | Company Description Juno Metabolomics is developing next-generation metabolomics for precision medicine. | Location Chapel Hill |
| |
Company MDxHealth Inc. | Activity: Research and Development | Company Description MDxHealth develops epigenetic technologies to personalize the diagnosis and treatment of cancer. | Location Hillsborough |
| |
Company Phytobiotics North America LLC | Activity: Sales and Operations | Company Description Phytobiotics produces and distributes botanical and phytogenic supplements and flavors for plant and animal nutrition. Additionally, Phytobiotics provides consultative services focused on intestinal health and increased nutrient bioavailability. | Location Cary |
| |
Company Phytonix Corp. | Activity: Research and Development | Company Description Phytonix develops and commercializes technologies and production processes that photosynthetically convert CO2, with solar energy and water, into low-cost solar chemicals and fuels such as butanols and octonols. | Location Black Mountain |
| |
Company Resilient Biotics Inc. | Activity: Research and Development | Company Description Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. Resilient utilizes a proprietary discovery platform for product development and has a broad pipeline across multiple species. | Location Durham |
| |
Company Symberix Inc. | Activity: Research and Development | Company Description Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases such as Inflammatory Bowel Disorder (IBD) as well as mitigate the lower GI side effects associated with various pain, cancer and immunosuppressive therapies. | Location Durham |
| |
Company Triangle Biotechnology Inc. | Activity: Research and Development | Company Description Triangle Biotechnology develops sonication reagents that enable efficient acoustic processing of biological samples for next generation sequencing and epigenetic assays. | Location Research Triangle Park |
| |
Company Vascular BioSciences Inc. | Activity: Research and Development | Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. | Location Durham |